ADO 0.00% 2.1¢ anteotech ltd

Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-140

  1. 2,640 Posts.
    lightbulb Created with Sketch. 427
    I view an interim result that can’t move forward as designed as a fail.

    Additional work required to address this (I am guessing) was not economically viable hence the trial halt.

    I agree the release did not use the word “fail”, that’s just how I read it.

    I agree I could be wrong and maybe the trial was never worthwhile due to the commons list ending next year.

    I remain invested and retain hope.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.